318
Participants
Start Date
June 16, 2014
Primary Completion Date
July 30, 2019
Study Completion Date
August 27, 2019
Rociletinib
Rociletinib will be administered to patients orally
National Taiwan University Hospital, Taipei
Centre Hospitalier Universitaire Vaudoise, Lausanne
Royal North Shore Hospital, Sydney
Westmead Hospital, Westmead
Icon Cancer Centre, South Brisbane
Flinders Medical Centre, Bedford Park
Montefiore Medical Center, The Bronx
Taipei Veterans General Hospital, Taipei
Evangelische Lungenklinik Berlin, Berlin
Centre Hospitalier Universitaire Hôpital Nord, Marseille
University of Rochester, Rochester
Fox Chase Cancer Center, Philadelphia
Virginia Cancer Specialists, Fairfax
LungenClinic Großhansdorf GmbH, Großhansdorf
Pius Hospital Oldenburg, Oldenburg
Yale University School of Medicine, New Haven
Advanced Medical Specialties, Miami
Chang Gung Memorial Hospital Linkou, Taoyuan District
Cleveland Clinic Florida, Weston
Tennessee Oncology, PLLC, Nashville
China Medical University Hospital, Taichung
Taichung Veterans General Hospital, Taichung
Hospital Universitario Virgen del Rocio, Seville
University Hospitals of Cleveland, Cleveland
Cleveland Clinic, Cleveland
Universitätsklinikum Essen, Essen
Universitätsklinikum Köln, Cologne
Universitaetsklinikum Bonn - Zentrum fuer Innere Medizin - Medizinische Klinik und Poliklink III, Bonn
Minnesota Oncology Hematology, P.A, Minneapolis
Mayo Clinic - Rochester, Rochester
Goethe-Universität Frankfurt am Main, Frankfurt am Main
Northwestern University Feinberg School of Medicine, Chicago
University of Illinois Chicago, Chicago
Illinois Cancer Specialists, Niles
Washington University School of Medicine, St Louis
Centre Hospitalier Lyon Sud, Pierre Bénité Cedex
Hôpital Tenon, Paris
Texas Oncology P.A., Flower Mound
Texas Oncology P.A., Dallas
USO - Texas Oncology P.A., Arlington
Texas Oncology P.A., Bedford
The Methodist Hospital, Houston
Texas Oncology-Beaumont, Beaumont
Texas Oncology-Austin Central, Austin
Texas Oncology P.A., Amarillo
Rocky Mountain Cancer Centers, LLP, Lone Tree
Klinikum Innenstadt LMU, München
Asklepios Fachkliniken München-Gauting, Gauting
Cancer Care Associates, Redondo Beach
Northridge Hospital Medical Center, Northridge
UCLA Medical Center, Alhambra
University of California San Diego Moores Cancer Center, La Jolla
Saint Jude Heritage Healthcare, Fullerton
Comprehensive Blood and Cancer Center, Bakersfield
Coastal Integrative Cancer Care, San Luis Obispo
University of California San Francisco, San Francisco
Institut Gustave Roussy, Villejuif
University of California Davis Medical Center, Sacramento
Northwest Cancer Specialists, P.C., Vancouver
Yakima Valley Memorial Hospital, North Star Lodge, Yakima
Saint Mary's Regional Cancer Center, Grand Junction
Beth Israel Comprehensive Cancer Center, Boston
Lahey Hospital and Medical Center, Burlington
New York Oncology Hematology, PC, Latham
Texas Oncology - Plano East, Plano
Princess Margaret Hospital, Toronto
Centre Hospitalier Regional Universitaire (CHRU) de Besancon - L'Hopital Jean Minjoz, Besançon
Institut de Cancérologie de l'Ouest - René Gauducheau, Saint-Herblain
Centre Hospitalier Universitaire Côte de Nacre, Caen
Queen Mary Hospital, Hong Kong
National Cancer Center, Goyang-si
Chungbuk National University Hospital, Chungju
Dong-A University Hospital, Busan
Asan Medical Center, Seoul
Seoul National University Hospital, Seoul
Seoul Saint Mary's Hospital, Seoul
Severance Hospital, Yonsei University Health System, Seoul
Hospital Universitari Germans Trias i Pujol, Badalona
Hospital Universitario Quirón Dexeus, Barcelona
Hospital Universitario La Paz, Madrid
Antoni van Leeuwenhoek Hospital, Amsterdam
Vrije Universiteit Medisch Centrum, Amsterdam
Gachon University Gil Medical Center, Incheon
Inha University Hospital, Incheon
Samsung Medical Center, Seoul
Hospital Vall d´Hebrón, Barcelona
Cambridge University Hospitals NHS Foundation Trust, Cambridge
Guy's and Saint Thomas NHS Foundation Trust, London
Royal Marsden Hospital, London
Royal Marsden NHS Trust, Sutton
University College Hospital, London
Lead Sponsor
Clovis Oncology, Inc.
INDUSTRY